NewcelX Ltd.(NCEL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NCEL NewcelX Ltd.

休市中 12-12 16:00:00 EST

2.91

-0.42

-12.61%

盘后2.80

-0.11-3.78%

19:48 EST

最高3.51	最低2.91	成交量11.40万
今开3.31	昨收3.33	日振幅18.02%
总市值1,326万	流通市值1,326万	总股本455.84万
成交额36.26万	换手率2.50%	流通股本455.84万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NCEL","market":"US","secType":"STK","nameCN":"NewcelX Ltd.","latestPrice":2.91,"timestamp":1765573200000,"preClose":3.33,"halted":0,"volume":113981,"hourTrading":{"tag":"盘后","latestPrice":2.8001,"preClose":2.91,"latestTime":"19:48 EST","volume":2855,"amount":8171.9818,"timestamp":1765586927660},"delay":0,"floatShares":4558400,"shares":4558400,"eps":-26.28804,"marketStatus":"休市中","change":-0.42,"latestTime":"12-12 16:00:00 EST","open":3.31,"high":3.51,"low":2.91,"amount":362598.6140238,"amplitude":0.18018,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-26.28804,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1611896400000,"exchange":"NASDAQ","adjPreClose":3.33,"preHourTrading":{"tag":"盘前","latestPrice":3.65,"preClose":3.33,"latestTime":"09:24 EST","volume":335,"amount":1226.0197675,"timestamp":1765549468328},"postHourTrading":{"tag":"盘后","latestPrice":2.8001,"preClose":2.91,"latestTime":"19:48 EST","volume":2855,"amount":8171.9818,"timestamp":1765586927660},"volumeRatio":0.5385738452852552},"requestUrl":"/m/hq/s/NCEL/tweets","defaultTab":"tweets","newsList":[{"id":"1143544598","title":"NewcelX有限公司通过任命Barrow神经科学研究所首席医疗官Jeremy Shefner博士增强科学顾问委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=1143544598","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143544598?lang=zh_cn&edition=full","pubTime":"2025-11-17 20:02","pubTimestamp":1763380947,"startTime":"0","endTime":"0","summary":"NewcelX有限公司通过任命Barrow神经科学研究所首席医疗官Jeremy Shefner博士增强科学顾问委员会","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NCEL"],"gpt_icon":0},{"id":"1199796406","title":"NewcelX 在与 NLS Pharmaceutics Ltd. 合并后提供业务和战略路线图更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1199796406","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199796406?lang=zh_cn&edition=full","pubTime":"2025-11-03 21:27","pubTimestamp":1762176430,"startTime":"0","endTime":"0","summary":"NewcelX 在与 NLS Pharmaceutics Ltd. 合并后提供业务和战略路线图更新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NCEL"],"gpt_icon":0},{"id":"1166589130","title":"NLS Pharmaceutics：在与Kadimastem合并后，合并公司将继续推进Itol-102项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1166589130","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166589130?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:22","pubTimestamp":1761736977,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics：在与Kadimastem合并后，合并公司将继续推进Itol-102项目","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","BK4007","NCEL"],"gpt_icon":0},{"id":"1171878787","title":"NLS Pharmaceutics Ltd. 宣布进行1比10的反向股票拆分并更改名称，以配合与Kadimastem的拟议合并","url":"https://stock-news.laohu8.com/highlight/detail?id=1171878787","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171878787?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:00","pubTimestamp":1761732022,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics Ltd. 宣布进行1比10的反向股票拆分并更改名称，以配合与Kadimastem的拟议合并。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NLSPW","NLSP","NCEL"],"gpt_icon":0},{"id":"1176769345","title":"NLS Pharmaceutics与Kadimastem宣布合并交易的重大前提条件已完成以及Kadimastem股票的退市日期","url":"https://stock-news.laohu8.com/highlight/detail?id=1176769345","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176769345?lang=zh_cn&edition=full","pubTime":"2025-10-29 15:54","pubTimestamp":1761724465,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics与Kadimastem宣布合并交易的重大前提条件已完成，并确认Kadimastem股票的退市日期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCEL","BK4007","NLSP"],"gpt_icon":0},{"id":"1131118792","title":"NLS Pharmaceutics与Kadimastem宣布Kadimastem与Targetgene之间的战略合作，以推动下一代基因编辑细胞疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1131118792","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131118792?lang=zh_cn&edition=full","pubTime":"2025-10-27 19:02","pubTimestamp":1761562934,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics与Kadimastem宣布Kadimastem与Targetgene之间的战略合作，以推动下一代基因编辑细胞疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCEL","NLSPW","NLSP","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nlspharma.com","stockEarnings":[{"period":"1week","weight":-0.2005},{"period":"1month","weight":-0.2092},{"period":"3month","weight":-0.8647},{"period":"6month","weight":-0.8724},{"period":"1year","weight":-0.8515},{"period":"ytd","weight":-0.8621}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NewcelX Ltd.于2015年6月成立。 该公司是一家创新的生物制药公司，致力于发现和开发可改善罕见中枢神经系统疾病的改善生命的药物疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.055387},{"month":2,"riseRate":0.4,"avgChangeRate":-0.001667},{"month":3,"riseRate":0.6,"avgChangeRate":-0.007458},{"month":4,"riseRate":0,"avgChangeRate":-0.175846},{"month":5,"riseRate":0.4,"avgChangeRate":0.007372},{"month":6,"riseRate":0.6,"avgChangeRate":0.133578},{"month":7,"riseRate":0.2,"avgChangeRate":-0.210549},{"month":8,"riseRate":0.6,"avgChangeRate":0.043884},{"month":9,"riseRate":0.4,"avgChangeRate":-0.067099},{"month":10,"riseRate":0,"avgChangeRate":-0.247213},{"month":11,"riseRate":0.2,"avgChangeRate":-0.070852},{"month":12,"riseRate":0.4,"avgChangeRate":-0.028836}],"exchange":"NASDAQ","name":"NewcelX Ltd.","nameEN":"NewcelX Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NewcelX Ltd.(NCEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NewcelX Ltd.(NCEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NewcelX Ltd.,NCEL,NewcelX Ltd.股票,NewcelX Ltd.股票老虎,NewcelX Ltd.股票老虎国际,NewcelX Ltd.行情,NewcelX Ltd.股票行情,NewcelX Ltd.股价,NewcelX Ltd.股市,NewcelX Ltd.股票价格,NewcelX Ltd.股票交易,NewcelX Ltd.股票购买,NewcelX Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NewcelX Ltd.(NCEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NewcelX Ltd.(NCEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}